USD 1.03
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 3.76 Billion JPY | 50.19% |
2023 | 2.93 Billion JPY | 48.11% |
2022 | 1.98 Billion JPY | -15.18% |
2021 | 2.33 Billion JPY | 13.66% |
2020 | 2.05 Billion JPY | 0.0% |
2019 | 2.05 Billion JPY | 10.35% |
2018 | 1.86 Billion JPY | -17.19% |
2017 | 2.25 Billion JPY | 4.41% |
2016 | 2.15 Billion JPY | 5.81% |
2015 | 2.03 Billion JPY | 49.32% |
2014 | 1.36 Billion JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 763 Million JPY | -12.7% |
2024 Q1 | 874 Million JPY | 23.8% |
2024 Q3 | 773 Million JPY | 1.31% |
2024 FY | 3.76 Billion JPY | 28.16% |
2024 Q4 | 1.31 Billion JPY | 70.63% |
2023 Q4 | 706 Million JPY | -11.75% |
2023 Q1 | 668 Million JPY | -4.16% |
2023 Q2 | 763 Million JPY | 14.22% |
2023 Q3 | 800 Million JPY | 4.85% |
2023 FY | 2.93 Billion JPY | 48.11% |
2022 FY | 1.98 Billion JPY | -15.18% |
2022 Q4 | 697 Million JPY | 29.07% |
2022 Q3 | 540 Million JPY | 0.19% |
2022 Q2 | 539 Million JPY | -3.75% |
2022 Q1 | 560 Million JPY | -10.83% |
2021 Q2 | 433 Million JPY | -10.17% |
2021 Q4 | 628 Million JPY | 42.08% |
2021 FY | 2.33 Billion JPY | 13.66% |
2021 Q1 | 482 Million JPY | -45.1% |
2021 Q3 | 442 Million JPY | 2.08% |
2020 Q4 | 878 Million JPY | 80.66% |
2020 Q3 | 486 Million JPY | -5.63% |
2020 FY | 2.05 Billion JPY | 0.0% |
2020 Q1 | 459 Million JPY | -42.12% |
2020 Q2 | 515 Million JPY | 12.2% |
2019 Q3 | 466 Million JPY | 28.02% |
2019 FY | 2.05 Billion JPY | 10.35% |
2019 Q1 | 437 Million JPY | 95.32% |
2019 Q2 | 364 Million JPY | -16.7% |
2019 Q4 | 793 Million JPY | 70.17% |
2018 Q4 | 223.73 Million JPY | -38.87% |
2018 FY | 1.86 Billion JPY | -17.19% |
2018 Q3 | 366 Million JPY | -8.5% |
2018 Q2 | 400 Million JPY | -27.6% |
2018 Q1 | 552.49 Million JPY | -8.02% |
2017 Q2 | 541.3 Million JPY | 0.35% |
2017 Q1 | 539.39 Million JPY | -21.81% |
2017 Q4 | 600.68 Million JPY | 5.44% |
2017 Q3 | 569.68 Million JPY | 5.24% |
2017 FY | 2.25 Billion JPY | 4.41% |
2016 Q2 | 467.4 Million JPY | 10.46% |
2016 Q4 | 689.81 Million JPY | 19.86% |
2016 FY | 2.15 Billion JPY | 5.81% |
2016 Q3 | 575.53 Million JPY | 23.13% |
2016 Q1 | 423.16 Million JPY | -45.16% |
2015 Q1 | 344.19 Million JPY | -42.03% |
2015 Q2 | 436.78 Million JPY | 26.9% |
2015 Q4 | 771.56 Million JPY | 59.07% |
2015 FY | 2.03 Billion JPY | 49.32% |
2015 Q3 | 485.04 Million JPY | 11.05% |
2014 FY | 1.36 Billion JPY | 0.0% |
2014 Q4 | 593.79 Million JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
AVITA Medical, Inc. | 80.77 Million USD | -4559.614% |
Manhattan Scientifics, Inc. | 703 Thousand USD | -535319.63% |
Össur hf. | 396.18 Million USD | -850.059% |
QHSLab, Inc. | 961.65 Thousand USD | -391309.375% |
Wellstar International, Inc. | 1.79 Million USD | -209629.113% |
Össur hf. | 396.18 Million USD | -850.059% |
CVR Medical Corp. | - USD | -Infinity% |
Bionovate Technologies Corp | - USD | -Infinity% |
Escalon Medical Corp. | 5.25 Million USD | -71586.117% |
Aurora Spine Corporation | 8.65 Million USD | -43376.815% |
BrainsWay Ltd. | 28.01 Million USD | -13334.221% |
Lattice Biologics Ltd. | - USD | -Infinity% |
BioElectronics Corporation | 740.67 Thousand USD | -508084.415% |
Hamilton Thorne Ltd. | 33.57 Million USD | -11111.534% |
Vivos Inc. | 2.78 Million USD | -134950.285% |
Kelyniam Global, Inc. | 2.27 Million USD | -165332.806% |
REMSleep Holdings, Inc. | 1.01 Million USD | -370772.881% |
Zecotek Photonics Inc. | 3.46 Million USD | -108640.682% |
Avitar, Inc. | 3.56 Million USD | -105348.558% |
Nanomix Corporation | 8.36 Million USD | -44882.438% |
EKF Diagnostics Holdings plc | 21.77 Million USD | -17183.497% |
Theraclion SA | 7.43 Million USD | -50492.54% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Positron Corporation | 1 Million USD | -373577.758% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | 3.11 Million USD | -120911.585% |
Lombard Medical, Inc. | 30.29 Million USD | -12326.543% |
ALR Technologies Inc. | 6.33 Million USD | -59306.603% |
Stratec SE | 46.32 Million USD | -8026.013% |
Vycor Medical, Inc. | 1.27 Million USD | -295008.521% |
Heart Tronics, Inc. | 14.46 Million USD | -25930.278% |
MicroPort Scientific Corporation | 1.04 Billion USD | -259.07% |
VMS Rehab Systems, Inc. | 63.63 USD | -5915448587.726% |
NewCardio, Inc. | 9.56 Million USD | -39254.519% |
Guided Therapeutics, Inc. | 3.49 Million USD | -107658.374% |
Ingen Technologies, Inc. | 1.88 Million USD | -199876.517% |
Odyssey Group International, Inc. | -14.26 Million USD | 26493.522% |
CYduct Diagnostics, Inc. | 435.5 Thousand USD | -864193.915% |
Wellness Center USA, Inc. | 1.29 Million USD | -290651.117% |
SANUWAVE Health, Inc. | 14.15 Million USD | -26498.827% |
IR-Med Inc. | 4.89 Million USD | -76810.503% |
Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -1823375.552% |
Polarean Imaging plc | 12.24 Million USD | -30645.455% |
United American Healthcare Corporation | 59 Thousand USD | -6379561.017% |
ECGI Holdings, Inc. | 407.48 Thousand USD | -923614.983% |
Nu-Med Plus, Inc. | 120.52 Thousand USD | -3122877.615% |
Capital Group Holdings, Inc. | 634.68 Thousand USD | -592947.293% |
ADM Tronics Unlimited, Inc. | 1.69 Million USD | -221890.9% |
Medical Supply International USA, Inc. | 1.32 Million USD | -284944.408% |
Urologix, Inc. | 10.09 Million USD | -37196.869% |
Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -297842.031% |
Nexeon MedSystems Inc. | 5.94 Million USD | -63178.563% |
SS Innovations International, Inc. | 21.38 Million USD | -17503.74% |
Qualis Innovations, Inc. | 230.24 Thousand USD | -1634708.744% |
Smith & Nephew plc | 3.46 Billion USD | -8.566% |
NIOX Group Plc | 22.27 Million USD | -16795.971% |
Fuse Medical, Inc. | 10.35 Million USD | -36267.097% |
Broncus Holding Corporation | 38.15 Million USD | -9766.047% |
Brain Scientific Inc. | 9.66 Million USD | -38853.787% |
Pressure BioSciences, Inc. | 10.3 Million USD | -36433.332% |
Health Logic Interactive Inc. | 60.69 Thousand USD | -6201092.791% |